Details

Autor(en) / Beteiligte

• Chan, Wai-Kin
• Horvath, Thomas D
• Tan, Lin
• Link, Todd
• Harutyunyan, Karine G
• Pontikos, Michael A
• Anishkin, Andriy
• Du, Di
• Martin, Leona A
• Yin, Eric
• Rempe, Susan B
• Sukharev, Sergei
• Konopleva, Marina
• Weinstein, John N
• Lorenzi, Philip L

Titel

Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia

Ist Teil von

• Molecular cancer therapeutics, 2019-09, Vol.18 (9), p.1587-1592

Ort / Verlag

United States

Erscheinungsjahr

2019

Quelle

EZB Free E-Journals

Beschreibungen/Notizen

• We and others have reported that the anticancer activity of L-asparaginase (ASNase) against asparagine synthetase (ASNS)-positive cell types requires ASNase glutaminase activity, whereas anticancer activity against ASNS-negative cell types does not. Here, we attempted to disentangle the relationship between asparagine metabolism, glutamine metabolism, and downstream pathways that modulate cell viability by testing the hypothesis that ASNase anticancer activity is based on asparagine depletion rather than glutamine depletion per se. We tested ASNase wild-type (ASNase ) and its glutaminase-deficient Q59L mutant (ASNase ) and found that ASNase glutaminase activity contributed to durable anticancer activity against xenografts of the ASNS-negative Sup-B15 leukemia cell line in NOD/SCID gamma mice, whereas asparaginase activity alone yielded a mere growth delay. Our findings suggest that ASNase glutaminase activity is necessary for durable, single-agent anticancer activity , even against ASNS-negative cancer types.